(Unaudited data)
Development of business in the third quarter (variation at current rate)
|
thousands of euros |
1 st Quarter | 2 nd Quarter | 3 rd Quarter | ||||||
| 2013 | 2014 |
Var.
14/13 |
2013 | 2014 |
Var.
14/13 |
2013 | 2014 |
Var.
14/13 |
|
| France | 84,270 | 82,749 | -1.8% | 75,327 | 74,269 | -1.4% | 92,596 | 92,466 | -0.1% |
| International : | 73,751 | 57,460 | -22.1% | 42,436 | 47,138 | +11.1% | 76,890 | 79,646 | +3.6% |
| Incl. Europe excluding France | 54,334 | 39,967 | -26.4% | 29,047 | 33,570 | +15.6% | 61,256 | 62,758 | +2.5% |
| Incl. North America | 15,562 | 12,662 | -18.6% | 10,017 | 10,625 | +6.1% | 12,153 | 13,109 | +7.9% |
| Incl. Other countries | 3,855 | 4,831 | +25.3% | 3,372 | 2,943 | -12.7% | 3,481 | 3,779 | +8.6% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | +3.1% | 169,486 | 172,112 | +1.5% |
|
thousands of euros |
1 st Quarter | 2 nd Quarter | 3 rd Quarter | ||||||
| 2013 | 2014 |
Var.
14/13 |
2013 | 2014 |
Var.
14/13 |
2013 | 2014 |
Var.
14/13 |
|
| Non-proprietary Homeopathic Medicines | 79,062 | 77,919 | -1.4% | 73,035 | 73,072 | +0.1% | 73,597 | 72,957 | -0.9% |
| OTC Specialties | 78,866 | 62,196 | -21.1% | 44,600 | 48,058 | +7.8% | 95,813 | 99,025 | + 3.4% |
| Other | 93 | 94 | +1.1% | 128 | 277 | +116.4% | 76 | 130 | +71.1% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | +3.1% | 169,486 | 172,112 | +1.5% |
Cumulative activity as of the end of september 2014
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 252,193 | 249,484 | - 1.1% | - 1.1% |
| International : | 193,077 | 184,244 | - 4.6% | - 1.2% |
| Incl. Europe excluding France | 144,637 | 136,295 | - 5.8% | - 2.4% |
| Incl. North America | 37,732 | 36,396 | - 3.5% | + 0.4% |
| Incl. Other countries | 10,708 | 11,553 | + 7.9% | + 10.2% |
| Group Total | 445,270 | 433,728 | - 2.6% | - 1.1% |
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 225,694 | 223,948 | - 0.8% | - 0.5% |
| OTC Specialties | 219,279 | 209,279 | - 4.6% | - 1.8% |
| Other | 297 | 501 | + 68.7% | + 63.6% |
| Group Total | 445,270 | 433,728 | - 2.6% | - 1.1% |
Highlights of the third quarter
-
Sales revenue in the third quarter 2014 grew by 1.5% compared to 2013 (3.3% at constant rates).
-
On September 30, 2014, the group cash balance amounted €134.7 million.
Outlook
Considering the uncertainty of seasonal illnesses in the last quarter, the group is still cautious regarding its 2014 outlook.
Our next update: January 22, 2015 at market close, publication of the sales revenue for the year 2014.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at
:
www.boiron.com
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-37682-BOI-231014-CA-T3-14-GB.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer